Hanumant Gambhire, Monica Gulati, Sachin Kumar Singh, Atul Nasa, and Neelu Goel. “AN OVERVIEW OF US FDA WARNING LETTERS TO INDIAN PHARMACEUTICAL INDUSTRIES FOR CGMP VIOLATIONS PERTAINING TO STERILE PRODUCTS”. Journal of Population Therapeutics and Clinical Pharmacology 29, no. 03 (August 20, 2022): 1845–1863. Accessed November 18, 2024. https://mail.jptcp.com/index.php/jptcp/article/view/7242.